. 2021 Jan 7;19(4):179–183. doi: 10.5114/pm.2020.101948

Table 3.

Relative risk (RR) of overweight, obesity, insulin resistance (IR), hypothyroidism, and hyperprolactinemia in PCOS women

Variable	PCOS women (study group) (n =120)	Non-PCOS controls (n =120)	Relative risk (95% CI); p-value
BMI 25-29.9 kg/m2	51 (42.5)	26 (21.7)	1.96 (1.3-2.9); 0.0009^*
BMI < 25 kg/m2	69 (57.5)	94 (78.3)	1.96 (1.3-2.9); 0.0009^*
BMI ≥ 30 kg/m2	47 (39.17)	19 (15.8)	2.4 (1.54-3.9); 0.0002^*
BMI < 30 Kg/m2	73 (60.83)	101 (84.2)	2.4 (1.54-3.9); 0.0002^*
WC > 35 inches	53 (44.17)	23 (19.17)	2.3 (1.5-3.5); 0.0001^*
WC < 35 inches	67 (55.13)	97 (80.83)	2.3 (1.5-3.5); 0.0001^*
G/I ratio < 4.5	57 (47.5)	19 (15.8)	3.0 (1.9-4.7); < 0.0001^*
G/I ratio > 4.5	63 (52.5)	101 (84.2)	3.0 (1.9-4.7); < 0.0001^*
TSH ≥ 4.1 mIU/ml	31 (25.8)	9 (7.5)	3.4 (1.7-6.9); 0.0005^*
TSH < 4.1 mIU/ml	89 (74.2)	111 (92.5)	3.4 (1.7-6.9); 0.0005^*
Prolactin > 29 ng/ml (> 614 mIU/ml)	41 (34.17)	13 (10.8)	3.15 (1.8-5.6); 0.0001^*
Prolactin < 29 ng/ml (< 614 mIU/ml)	79 (65.83)	107 (89.2)	3.15 (1.8-5.6); 0.0001^*

PCOS – polycystic ovary syndrome, WC – waist circumference, G/I – glucose/insulin, TSH – thyroid stimulating hormone, CI – confidence interval. ^* significant difference. Data presented as number and percentage (%)